Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Eurofins MWG OperonBIOTECH DNA/PROTEIN ANALYTICSContact:Dr. Jutta HuberAnzinger Str. 7aD-85560 EbersbergPhone: +49 (0) 8092 8289-0Fax: +49 (0) 8092 21084E-Mail: info-eu@eurofins.comInternet: www.eurofinsdna.comKeywords: Small Molecules, PCR, Automation, Antisense/Nucleotides,GenomicsEurofins MWG Operon, founded in 1990 and member of the Eurofins Group,is an international provider of genomic services established around thecore business lines next generation sequencing, custom DNA sequencing,oligo-nucleotides, siRNA and gene synthesis. The company‘s main missionis focussed on customer convenience and high quality services in industrialscale for the life science industries and academic research institutionsaround the world.Evotec AGBIOTECH PRECLINICAL SERVICESKeywords: Genomics, Proteomics, Metabolic Diseases, Drug Development,Small Molecules, Inflammation, OncologyContact:Dr. Andreas JenneAm Klopferspitz 19aD-82152 Martinsried/MünchenPhone: +49 (0) 89 4613363-0Fax: +49 (0) 89 4613363-20E-Mail: info@evotec.comInternet: www.evotec.comEvotec is a drug discovery alliance and development partnership companyfocused on rapidly progressing innovative product approaches with leadingpharmaceutical and biotechnology companies. The Company has establisheda unique position by assembling top-class scientific experts and integratingstate-of-the-art technologies as well as substantial experience andexpertise in key therapeutic areas including neuroscience, pain, metabolicdiseases as well as oncology and inflammation. Evotec has long-termdiscovery alliances with partners including Boehringer Ingelheim, CHDI,Genentech, Medimmune/Astra Zeneca, Novartis, Ono Pharmaceutical andRoche. The Company‘s headquarters are located in Hamburg. Additionalmajor technology and research facilities are based in Göttingen (formerDeveloGen AG) and Martinsried (former Kinaxo Biotechnologies GmbH),Abingdon, UK and Thane, India. Evotec has more than 550 employeesworldwide. For additional information please go to www.evotec.comEXCELLA GmbHPHARMA & CHEMICAL INDUSTRYContact:Dr. Johann Peter MörsdorfKeywords: Drug Development, Medicinal Chemistry, Analytical Chemistry,Small Molecules, OncologyNürnberger Str. 12D-90537 FeuchtPhone: +49 (0) 9128 4045-38Fax: +49 (0) 9128 4045-81E-Mail: pmoersdorf.excella@fareva.comInternet: www.excella-pharma-source.deExcella GmbH has been serving the pharmaceutical industry for more than35 years with high quality API‘s and finished dosage forms. Recent investmentshave directed our focus towards high containment products (includingOEB5) and a one-stop-shopping approach. Excella supplies products tothe generic industry but although manufactures for big pharma life cycleend products and develops processes for innovative API‘s and novel soliddosage forms. Services offered range from early product developmentthrough registration support to state-of-the-art manufacturing.Excella‘s Feucht site has an excellent track record with the FDA and otherregulatory agencies since 1983 and is Safebridge certified.60